| Editors |
|
ix | |
| Contributors |
|
xi | |
| Preface |
|
xiii | |
|
1 Historical Principles and Perspectives |
|
|
1 | (3) |
|
|
|
1 | (1) |
|
|
|
2 | (2) |
|
2 Toxicologic Misfortunes and Catastrophes in History |
|
|
4 | (3) |
|
|
|
4 | (1) |
|
|
|
5 | (2) |
|
3 Initial Evaluation of the Patient: Vital Signs and Toxic Syndromes |
|
|
7 | (3) |
|
|
|
7 | (1) |
|
|
|
8 | (2) |
|
4 Principles of Managing the Acutely Poisoned or Overdosed Patient |
|
|
10 | (3) |
|
|
|
10 | (1) |
|
|
|
11 | (2) |
|
5 Techniques Used to Prevent Gastrointestinal Absorption |
|
|
13 | (4) |
|
|
|
13 | (1) |
|
|
|
14 | (3) |
|
6 Principles and Techniques Applied to Enhance Elimination |
|
|
17 | (3) |
|
|
|
17 | (1) |
|
|
|
18 | (2) |
|
|
|
20 | (3) |
|
|
|
20 | (1) |
|
|
|
21 | (2) |
|
8 Principles of Diagnostic Imaging |
|
|
23 | (3) |
|
|
|
23 | (1) |
|
|
|
24 | (2) |
|
9 Pharmacokinetic and Toxicokinetic Principles |
|
|
26 | (3) |
|
|
|
26 | (1) |
|
|
|
27 | (2) |
|
|
|
29 | (3) |
|
|
|
29 | (1) |
|
|
|
30 | (2) |
|
11 Biochemical and Metabolic Principles |
|
|
32 | (3) |
|
|
|
32 | (1) |
|
|
|
33 | (2) |
|
12 Fluid, Electrolytes, and Acid-Base Principles |
|
|
35 | (3) |
|
|
|
35 | (1) |
|
|
|
36 | (2) |
|
13 Neurotransmitters and Neuromodulators |
|
|
38 | (3) |
|
|
|
38 | (1) |
|
|
|
39 | (2) |
|
|
|
41 | (3) |
|
|
|
41 | (1) |
|
|
|
42 | (2) |
|
15 Cardiologic Principles I: Electrophysiologic and Electrocardiographic Principles |
|
|
44 | (3) |
|
|
|
44 | (1) |
|
|
|
45 | (2) |
|
16 Cardiologic Principles II: Hemodynamics |
|
|
47 | (3) |
|
|
|
47 | (1) |
|
|
|
48 | (2) |
|
17 Dermatologic Principles |
|
|
50 | (3) |
|
|
|
50 | (1) |
|
|
|
51 | (2) |
|
18 Gastrointestinal Principles |
|
|
53 | (3) |
|
|
|
53 | (1) |
|
|
|
54 | (2) |
|
19 Genitourinary Principles |
|
|
56 | (3) |
|
|
|
56 | (1) |
|
|
|
57 | (2) |
|
20 Hematologic Principles |
|
|
59 | (3) |
|
|
|
59 | (1) |
|
|
|
60 | (2) |
|
|
|
62 | (3) |
|
|
|
62 | (1) |
|
|
|
63 | (2) |
|
|
|
65 | (3) |
|
|
|
65 | (1) |
|
|
|
66 | (2) |
|
|
|
68 | (3) |
|
|
|
68 | (1) |
|
|
|
69 | (2) |
|
|
|
71 | (3) |
|
|
|
71 | (1) |
|
|
|
72 | (2) |
|
25 Otolaryngologic Principles |
|
|
74 | (3) |
|
|
|
74 | (1) |
|
|
|
75 | (2) |
|
26 Psychiatric Principles |
|
|
77 | (3) |
|
|
|
77 | (1) |
|
|
|
78 | (2) |
|
|
|
80 | (3) |
|
|
|
80 | (1) |
|
|
|
81 | (2) |
|
28 Respiratory Principles |
|
|
83 | (3) |
|
|
|
83 | (1) |
|
|
|
84 | (2) |
|
29 Thermoregulatory Principles |
|
|
86 | (3) |
|
|
|
86 | (1) |
|
|
|
87 | (2) |
|
30 Reproductive and Perinatal Principles |
|
|
89 | (4) |
|
|
|
89 | (1) |
|
|
|
90 | (3) |
|
|
|
93 | (4) |
|
|
|
93 | (1) |
|
|
|
94 | (3) |
|
|
|
97 | (4) |
|
|
|
97 | (1) |
|
|
|
98 | (3) |
|
|
|
101 | (4) |
|
|
|
101 | (1) |
|
|
|
102 | (3) |
|
34 Colchicine, Podophyllin, and the Vinca Alkaloids |
|
|
105 | (3) |
|
|
|
105 | (1) |
|
|
|
106 | (2) |
|
35 Nonsteroidal Antiinflammatory Drugs |
|
|
108 | (3) |
|
|
|
108 | (1) |
|
|
|
109 | (2) |
|
|
|
111 | (3) |
|
|
|
111 | (1) |
|
|
|
112 | (2) |
|
|
|
114 | (4) |
|
|
|
114 | (1) |
|
|
|
115 | (3) |
|
|
|
118 | (3) |
|
|
|
118 | (1) |
|
|
|
119 | (2) |
|
|
|
121 | (3) |
|
|
|
121 | (1) |
|
|
|
122 | (2) |
|
40 Dieting Xenobiotics and Regimens |
|
|
124 | (3) |
|
|
|
124 | (1) |
|
|
|
125 | (2) |
|
41 Athletic Performance Enhancers |
|
|
127 | (3) |
|
|
|
127 | (1) |
|
|
|
128 | (2) |
|
|
|
130 | (3) |
|
|
|
130 | (1) |
|
|
|
131 | (2) |
|
43 Plant- and Animal-Derived Dietary Supplements |
|
|
133 | (3) |
|
|
|
133 | (1) |
|
|
|
134 | (2) |
|
|
|
136 | (3) |
|
|
|
136 | (1) |
|
|
|
137 | (2) |
|
|
|
139 | (3) |
|
|
|
139 | (1) |
|
|
|
140 | (2) |
|
46 Pharmaceutical Additives |
|
|
142 | (3) |
|
|
|
142 | (1) |
|
|
|
143 | (2) |
|
47 Antidiabetics and Hypoglycemics/Antiglycemics |
|
|
145 | (4) |
|
|
|
145 | (1) |
|
|
|
146 | (3) |
|
|
|
149 | (3) |
|
|
|
149 | (1) |
|
|
|
150 | (2) |
|
49 Antihistamines and Decongestants |
|
|
152 | (3) |
|
|
|
152 | (1) |
|
|
|
153 | (2) |
|
|
|
155 | (3) |
|
|
|
155 | (1) |
|
|
|
156 | (2) |
|
51 Methotrexate, 5-Fluorouracil, and Capecitabine |
|
|
158 | (3) |
|
|
|
158 | (1) |
|
|
|
159 | (2) |
|
52 Antimigraine Medications |
|
|
161 | (3) |
|
|
|
161 | (1) |
|
|
|
162 | (2) |
|
53 Thyroid and Antithyroid Medications |
|
|
164 | (3) |
|
|
|
164 | (1) |
|
|
|
165 | (2) |
|
54 Antibacterials, Antifungals, and Antivirals |
|
|
167 | (3) |
|
|
|
167 | (1) |
|
|
|
168 | (2) |
|
|
|
170 | (3) |
|
|
|
170 | (1) |
|
|
|
171 | (2) |
|
56 Antituberculous Medications |
|
|
173 | (4) |
|
|
|
173 | (1) |
|
|
|
174 | (3) |
|
|
|
177 | (3) |
|
|
|
177 | (1) |
|
|
|
178 | (2) |
|
|
|
180 | (4) |
|
|
|
180 | (1) |
|
|
|
181 | (3) |
|
59 Beta Adrenergic Antagonists |
|
|
184 | (3) |
|
|
|
184 | (1) |
|
|
|
185 | (2) |
|
60 Calcium Channel Blockers |
|
|
187 | (3) |
|
|
|
187 | (1) |
|
|
|
188 | (2) |
|
61 Miscellaneous Antihypertensives and Pharmacologically Related Agents |
|
|
190 | (3) |
|
|
|
190 | (1) |
|
|
|
191 | (2) |
|
|
|
193 | (4) |
|
|
|
193 | (1) |
|
|
|
194 | (3) |
|
63 Methylxanthines and Selective Beta2 Adrenergic Agonists |
|
|
197 | (3) |
|
|
|
197 | (1) |
|
|
|
198 | (2) |
|
|
|
200 | (3) |
|
|
|
200 | (1) |
|
|
|
201 | (2) |
|
65 Inhalational Anesthetics |
|
|
203 | (3) |
|
|
|
203 | (1) |
|
|
|
204 | (2) |
|
66 Neuromuscular Blockers |
|
|
206 | (3) |
|
|
|
206 | (1) |
|
|
|
207 | (2) |
|
|
|
209 | (3) |
|
|
|
209 | (1) |
|
|
|
210 | (2) |
|
68 Cyclic Antidepressants |
|
|
212 | (3) |
|
|
|
212 | (1) |
|
|
|
213 | (2) |
|
69 Serotonin Reuptake Inhibitors and Atypical Antidepressants |
|
|
215 | (3) |
|
|
|
215 | (1) |
|
|
|
216 | (2) |
|
|
|
218 | (4) |
|
|
|
218 | (1) |
|
|
|
219 | (3) |
|
71 Monoamine Oxidase Inhibitors |
|
|
222 | (3) |
|
|
|
222 | (1) |
|
|
|
223 | (2) |
|
|
|
225 | (4) |
|
|
|
225 | (1) |
|
|
|
226 | (3) |
|
|
|
229 | (4) |
|
|
|
229 | (1) |
|
|
|
230 | (3) |
|
|
|
233 | (3) |
|
|
|
233 | (1) |
|
|
|
234 | (2) |
|
|
|
236 | (4) |
|
|
|
236 | (1) |
|
|
|
237 | (3) |
|
|
|
240 | (4) |
|
|
|
240 | (1) |
|
|
|
241 | (3) |
|
|
|
244 | (4) |
|
|
|
244 | (1) |
|
|
|
245 | (3) |
|
78 Disulfiram and Disulfiramlike Reactions |
|
|
248 | (3) |
|
|
|
248 | (1) |
|
|
|
249 | (2) |
|
|
|
251 | (3) |
|
|
|
251 | (1) |
|
|
|
252 | (2) |
|
80 Gamma-Hydroxybutyric Acid (GHB) |
|
|
254 | (3) |
|
|
|
254 | (1) |
|
|
|
255 | (2) |
|
|
|
257 | (3) |
|
|
|
257 | (1) |
|
|
|
258 | (2) |
|
|
|
260 | (4) |
|
|
|
260 | (1) |
|
|
|
261 | (3) |
|
83 Phencyclidineand Ketamine |
|
|
264 | (3) |
|
|
|
264 | (1) |
|
|
|
265 | (2) |
|
|
|
267 | (3) |
|
|
|
267 | (1) |
|
|
|
268 | (2) |
|
|
|
270 | (3) |
|
|
|
270 | (1) |
|
|
|
271 | (2) |
|
|
|
273 | (3) |
|
|
|
273 | (1) |
|
|
|
274 | (2) |
|
|
|
276 | (3) |
|
|
|
276 | (1) |
|
|
|
277 | (2) |
|
|
|
279 | (3) |
|
|
|
279 | (1) |
|
|
|
280 | (2) |
|
|
|
282 | (3) |
|
|
|
282 | (1) |
|
|
|
283 | (2) |
|
|
|
285 | (3) |
|
|
|
285 | (1) |
|
|
|
286 | (2) |
|
|
|
288 | (3) |
|
|
|
288 | (1) |
|
|
|
289 | (2) |
|
|
|
291 | (4) |
|
|
|
291 | (1) |
|
|
|
292 | (3) |
|
|
|
295 | (3) |
|
|
|
295 | (1) |
|
|
|
296 | (2) |
|
|
|
298 | (3) |
|
|
|
298 | (1) |
|
|
|
299 | (2) |
|
|
|
301 | (3) |
|
|
|
301 | (1) |
|
|
|
302 | (2) |
|
|
|
304 | (3) |
|
|
|
304 | (1) |
|
|
|
305 | (2) |
|
|
|
307 | (3) |
|
|
|
307 | (1) |
|
|
|
308 | (2) |
|
|
|
310 | (3) |
|
|
|
310 | (1) |
|
|
|
311 | (2) |
|
|
|
313 | (4) |
|
|
|
313 | (1) |
|
|
|
314 | (3) |
|
|
|
317 | (3) |
|
|
|
317 | (1) |
|
|
|
318 | (2) |
|
101 Antiseptics, Disinfectants, and Sterilants |
|
|
320 | (3) |
|
|
|
320 | (1) |
|
|
|
321 | (2) |
|
102 Camphor and Moth Repellents |
|
|
323 | (3) |
|
|
|
323 | (1) |
|
|
|
324 | (2) |
|
|
|
326 | (4) |
|
|
|
326 | (1) |
|
|
|
327 | (3) |
|
104 Hydrofluoric Acid and Fluorides |
|
|
330 | (4) |
|
|
|
330 | (1) |
|
|
|
331 | (3) |
|
|
|
334 | (4) |
|
|
|
334 | (1) |
|
|
|
335 | (3) |
|
|
|
338 | (4) |
|
|
|
338 | (1) |
|
|
|
339 | (3) |
|
|
|
342 | (3) |
|
|
|
342 | (1) |
|
|
|
343 | (2) |
|
|
|
345 | (3) |
|
|
|
345 | (1) |
|
|
|
346 | (2) |
|
|
|
348 | (3) |
|
|
|
348 | (1) |
|
|
|
349 | (2) |
|
110 Insecticides: Organic Phosphorus Compounds and Carbamates |
|
|
351 | (4) |
|
|
|
351 | (1) |
|
|
|
352 | (3) |
|
111 Insecticides: Organic Chlorines, Pyrethrins/Pyrethroids, and Insect Repellents |
|
|
355 | (3) |
|
|
|
355 | (1) |
|
|
|
356 | (2) |
|
|
|
358 | (3) |
|
|
|
358 | (1) |
|
|
|
359 | (2) |
|
113 Sodium Monofluoroacetate and Fluoroacetamide |
|
|
361 | (3) |
|
|
|
361 | (1) |
|
|
|
362 | (2) |
|
|
|
364 | (3) |
|
|
|
364 | (1) |
|
|
|
365 | (2) |
|
|
|
367 | (3) |
|
|
|
367 | (1) |
|
|
|
368 | (2) |
|
|
|
370 | (3) |
|
|
|
370 | (1) |
|
|
|
371 | (2) |
|
|
|
373 | (3) |
|
|
|
373 | (1) |
|
|
|
374 | (2) |
|
|
|
376 | (3) |
|
|
|
376 | (1) |
|
|
|
377 | (2) |
|
119 Native (US) Venomous Snakes and Lizards |
|
|
379 | (3) |
|
|
|
379 | (1) |
|
|
|
380 | (2) |
|
|
|
382 | (3) |
|
|
|
382 | (1) |
|
|
|
383 | (2) |
|
121 Simple Asphyxiants and Pulmonary Irritants |
|
|
385 | (4) |
|
|
|
385 | (1) |
|
|
|
386 | (3) |
|
|
|
389 | (4) |
|
|
|
389 | (1) |
|
|
|
390 | (3) |
|
123 Cyanide and Hydrogen Sulfide |
|
|
393 | (3) |
|
|
|
393 | (1) |
|
|
|
394 | (2) |
|
124 Methemoglobin Inducers |
|
|
396 | (4) |
|
|
|
396 | (1) |
|
|
|
397 | (3) |
|
|
|
400 | (3) |
|
|
|
400 | (1) |
|
|
|
401 | (2) |
|
|
|
403 | (3) |
|
|
|
403 | (1) |
|
|
|
404 | (2) |
|
|
|
406 | (3) |
|
|
|
406 | (1) |
|
|
|
407 | (2) |
|
|
|
409 | (3) |
|
|
|
409 | (1) |
|
|
|
410 | (2) |
|
129 Poison Prevention and Education |
|
|
412 | (3) |
|
|
|
412 | (1) |
|
|
|
413 | (2) |
|
130 Poison Control Centers and Poison Epidemiology |
|
|
415 | (3) |
|
|
|
415 | (1) |
|
|
|
416 | (2) |
|
131 Principles of Occupational Toxicology: Diagnosis and Control |
|
|
418 | (3) |
|
|
|
418 | (1) |
|
|
|
419 | (2) |
|
132 Hazardous Materials Incident Response |
|
|
421 | (3) |
|
|
|
421 | (1) |
|
|
|
422 | (2) |
|
133 Risk Assessment and Risk Communication |
|
|
424 | (3) |
|
|
|
424 | (1) |
|
|
|
425 | (2) |
|
134 Medication Safety and Adverse Drug Events |
|
|
427 | (3) |
|
|
|
427 | (1) |
|
|
|
428 | (2) |
|
135 Drug Development, Adverse Drug Events, and Postmarketing Surveillance |
|
|
430 | (3) |
|
|
|
430 | (1) |
|
|
|
431 | (2) |
|
136 International Perspectives on Medical Toxicology |
|
|
433 | (3) |
|
|
|
433 | (1) |
|
|
|
434 | (2) |
|
137 Principles of Epidemiology and Research Design |
|
|
436 | (3) |
|
|
|
436 | (1) |
|
|
|
437 | (2) |
|
138 Risk Management and Legal Principles |
|
|
439 | (4) |
|
|
|
439 | (1) |
|
|
|
440 | (3) |
|
139 Medicolegal Interpretive Toxicology |
|
|
443 | (3) |
|
|
|
443 | (1) |
|
|
|
444 | (2) |
|
140 Postmortem Toxicology |
|
|
446 | |
|
|
|
446 | (2) |
|
|
|
448 | |
Lisainfo e-raamatute kohta